DIE BRUDER ZIMMERMANNHOFMANN S; BAUR M.1973, 48 p.Book

Adorno and Heidegger on art in the modern world = Adorno et Heidegger à propos de l'art dans le monde moderneBAUR, M.Philosophy today (Celina). 1996, Vol 40, Num 3, pp 357-366, issn 0031-8256Article

Hegel and aquinas on self-knowledge and historicityBAUR, M.The American Catholic philosophical quarterly. 1994, Vol 68, pp 125-134, issn 1051-3558, SUPArticle

Heidegger and Aquinas on the self as substanceBAUR, M.The American Catholic philosophical quarterly. 1996, Vol 70, Num 3, pp 317-337, issn 1051-3558Article

On the Aim of Scientific Theories in Relating to the World : A Defense of the Semantic AccountBAUR, M.Dialogue. Canadian Philosophical Association. 1990, Vol 29, Num 3, pp 323-333, issn 0012-2173Article

Children's Conception of Social Institutions: A Piagetian FrameworkFURTH H. G; BAUR M; SMITH J. E et al.Human Development. 1976, Vol 19, Num 6, pp 351-374Article

EINFLUSS NICHTPERIODISCHER REIZE AUF DIE VARIABILITAET VISUELL EVOZIERTER KORTIKALER POTENTIALE = INFLUENCE DE STIMULATIONS NON PERIODIQUES SUR LA VARIABILITE DES POTENTIELS CORTICAUX EVOQUES VISUELSSTODTMEISTER R; WILMANNS I; BAUR M et al.1981; DEV. OPHTHALMOL.; ISSN 0250-3751; CHE; DA. 1981; VOL. 3; PP. 194-215; BIBL. 3 P.Article

CHILDREN'S CONCEPTION OF SOCIAL INSTITUTIONS: A PIAGETIAN FRAMEWORK.FURTH HG; BAUR M; SMITH JE et al.1976; HUM. DEVELOP.; SWITZ.; DA. 1976; VOL. 19; NO 6; PP. 351-374; BIBL. 5 REF.Article

Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitorsMARTIN, S. F; DORSEY, G. O; GULNIK, S. V et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 10, pp 1581-1597, issn 0022-2623Article

Recognition of air pollution stress on Norway spruce (Picea abies L.) on the basis of multivariate analysis of biochemical parameters : A model field studySCHULZ, H; WEIDNER, M; BAUR, M et al.Angewandte Botanik. 1996, Vol 70, Num 1-2, pp 19-27, issn 0066-1759Article

Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patientsDITTRICH, C; BAUR, M; VAVRA, N et al.Annals of oncology. 1993, Vol 4, Num 8, pp 697-699, issn 0923-7534Article

PLOETZLICHER TOD DURCH MASSIVE LUFTEMBOLIE BEI RESPIRATOR-BEATMUNG IM NEUGEBORENENALTER = MORT SUBITE PAR EMBOLIE GAZEUSE MASSIVE CHEZ UN NOUVEAU-NE SOUS VENTILATION ARTIFICIELLEBAUR M; ORREN A; BRINER J et al.1979; HELV. PAEDIATR. ACTA; CHE; DA. 1979; VOL. 34; NO 2; PP. 147-153; ABS. FRE/ENG; BIBL. 7 REF.Article

Influence of human recombinant interferon-α2a (rhIFN-α2a) on altered lymphocyte subpopulations and monocytes in Behçet's diseaseTREUSCH, M; VONTHEIN, R; KÖTTER, I et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 10, pp 1275-1282, issn 1462-0324, 8 p.Article

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacementERIKSSON, B. I; WILLE-JØRGENSEN, P; CLOSE, P et al.The New England journal of medicine. 1997, Vol 337, Num 19, pp 1329-1335, issn 0028-4793Article

Valsartan : Long term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertensionBREMNER, A. D; BAUR, M; ODDOU-STOCK, P et al.Clinical and experimental hypertension (1993). 1997, Vol 19, Num 8, pp 1263-1285, issn 1064-1963Article

La maîtrise de la diffusion d'une innovation en Santé : le cas des immunoglobulines intraveineuses polyvalentes à l'Assistance Publique-Hôpitaux de Paris = Managing the diffusion of an innovating health care technique:the case of polyvalent intravenous immunoglobulins at the University Hospitals of ParisMINVIELLE, E; VIENS-BITKER, C; ROCHANT, H et al.Annales de médecine interne (Paris). 1995, Vol 146, Num 1, pp 19-24, issn 0003-410XArticle

Climbing the Jaynes-Cummings ladder and observing its √n nonlinearity in a cavity QED systemFINK, J. M; GÖPPL, M; BAUR, M et al.Nature (London). 2008, Vol 454, Num 7202, pp 315-318, issn 0028-0836, 4 p.Article

Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiationSTARK, H.-J; BAUR, M; BREITKREUTZ, D et al.Journal of investigative dermatology. 1999, Vol 112, Num 5, pp 681-691, issn 0022-202XArticle

Dossier : le médicamentBAUR, M; GHISLAIN, J.C; et al et al.LE NOUVEL HOSPITALIER. 1995, Num 33, pp 17-28Article

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancerDITTRICH, C; BAUR, M; KAUL, M et al.American journal of clinical oncology. 1990, Vol 13, pp S29-S39, issn 0277-3732, SUP1Conference Paper

Einfluss exogener Faktoren auf Altersschwerhörigkeit = Influence of exogenic factors on age-related hearing impairmentBAUR, M; FRANSEN, E; TROPITZSCH, A et al.HNO. Hals-, Nasen-, Ohrenärzte. 2009, Vol 57, Num 10, pp 1023-1028, issn 0017-6192, 6 p.Article

Mitochondriale A1555G-Mutation: Molekulargenetische Diagnostik bei sporadischen Fällen nichtsyndromaler Schwerhörigkeit = Molecular genetic diagnosis of the mitochondrial A1555G mutation in patients displaying sporadic non-syndromic hearing impairmentKUPKA, S; BODDEN-KAMPS, B; BAUR, M et al.HNO. Hals-, Nasen-, Ohrenärzte. 2004, Vol 52, Num 11, pp 968-972, issn 0017-6192, 5 p.Article

Octreotide combined with goserelin in the therapy of advanced pancreatic cancer-results of a pilot study and review of the literatureFAZENY, B; BAUR, M; PROHASKA, M et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 1, pp 45-52, issn 0171-5216Article

Prevention of thromboembolism with use of recombinant hirudin : Results of a double-blind, Multicenter Trial Comparing of Desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacementERIKSSON, B. I; EKMAN, S; LINDBRATT, S et al.Journal of bone and joint surgery. American volume. 1997, Vol 79, Num 3, pp 326-333, issn 0021-9355Article

Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerMADER, R. M; ZILG, H; SCHLAPPACK, O et al.Cancer chemotherapy and pharmacology. 1995, Vol 37, Num 1-2, pp 91-96, issn 0344-5704Article